Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE (SHP)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 07/20 02:24:22 pm
4411 GBp   -0.75%
12:28pSHIRE : Form 8.3 -Shire PLC
PU
12:03pSHIRE : Form 8.5 (EPT/NON-RI) - Shire Plc
PU
11:53aSHIRE : Form 8.5 (EPT/RI) - Shire plc
PU
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
4324(c) 4366.5(c) 4404(c) 4444.5(c) 4420.5 Last
4 120 234 2 197 164 2 070 344 1 690 335 921 915 Volume
-0.37% +0.98% +0.86% +0.92% -0.54% Change
More quotes
Financials (USD)
Sales 2018 15 469 M
EBIT 2018 5 776 M
Net income 2018 2 899 M
Debt 2018 14 980 M
Yield 2018 0,64%
Sales 2019 15 810 M
EBIT 2019 6 081 M
Net income 2019 3 418 M
Debt 2019 10 729 M
Yield 2019 0,69%
P/E ratio 2018 17,60
P/E ratio 2019 15,37
EV / Sales2018 4,37x
EV / Sales2019 4,01x
Capitalization 52 621 M
More Financials
Company
Shire Plc is a biopharmaceutical company.It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin,... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of Shire
Trading Rating : Investor Rating :
More Ratings
Latest news on SHIRE
12:28pSHIRE : Form 8.3 -Shire PLC
PU
12:03pSHIRE : Form 8.5 (EPT/NON-RI) - Shire Plc
PU
11:53aSHIRE : Form 8.5 (EPT/RI) - Shire plc
PU
11:27aSHIRE : argenx receives milestone payment from strategic collaboration with Shir..
AQ
11:26aSHIRE : Servier group appoints David K. Lee as CEO of Servier Pharmaceuticals (U..
AQ
11:18aSHIRE : Form 8.5 - Shire Plc
PU
10:23aSHIRE : Form 8.3 - Shire PLC
PU
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/19SHIRE PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/19SHIRE : Form 8.5 (EPT/RI) - Replacement of Shireplc
PU
More news
Sector news : Pharmaceuticals - NEC
01:40pASTRAZENECA : EU drug regulators step up work to prepare for 'no deal' Brexit
RE
09:06aBattle lines drawn as EU court weighs fate of gene-edited crops
RE
08:48aMERCK AND : to Cut Drug Prices Amid Pressure -- WSJ
DJ
07/19AMGEN : and Cedars-Sinai in Collaboration for 'Health-Care Quality'
DJ
07/19MERCK AND : to Limit Drug-Price Increases, Cut Some Prices
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on SHIRE 
SHIRE - 2015
Sellers pressure likely to dominate
SELL
SHIRE - 2014
Benefit from the resuming bullish trend
BUY
More Strategies
Latest Tweets
12:28pShire : Form 8.3 -Shire PLC  
12:11pPrimary Immune Deficiency (PID) - 2018 Pipeline Insights featuring Shire, Gla.. 
12:03pShire : Form 8.5 (EPT/NON-RI) - Shire Plc  
11:18aShire : Form 8.5 - Shire Plc  
10:23aShire : Form 8.3 - Shire PLC  
More tweets
Qtime:182
News from SeekingAlpha
07/16DIVIDEND GROWTH 50 : Income Up Nearly 10%, Led By Kinder Morgan (Seriously!) 
07/16Merger Arbitrage Mondays - July 16, 2018 
07/12Drug prices still marching upward - Bloomberg 
07/11Big Pharma in the red after Pfizer backs away from price hikes 
07/10Pricing transparency law in California having effect, drug makers nix planned.. 
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Technical analysis trends SHIRE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 63,5 $
Spread / Average Target 9,8%
EPS Revisions
Managers
NameTitle
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Thomas J. W. Dittrich Chief Financial Officer & Director
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE13.96%52 621
JOHNSON & JOHNSON-8.53%342 779
PFIZER3.98%220 295
NOVARTIS-1.75%206 001
ROCHE HOLDING LTD.-5.90%203 399
MERCK AND COMPANY11.09%169 328